Coalinga Dialysis is a medicare approved dialysis facility center in Coalinga, California and it has 12 dialysis stations. It is located in Fresno county at 1147 Phelps Ave, Coalinga, CA, 93210. You can reach out to the office of Coalinga Dialysis at (559) 934-0690. This dialysis clinic is managed and/or owned by Davita. Coalinga Dialysis has the following ownership type - Profit. It was first certified by medicare in July, 2013. The medicare id for this facility is 552726 and it accepts patients under medicare ESRD program.
| Name | Coalinga Dialysis |
|---|---|
| Location | 1147 Phelps Ave, Coalinga, California |
| No. of Dialysis Stations | 12 |
| Medicare ID | 552726 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1147 Phelps Ave, Coalinga, California, 93210 | |
| (559) 934-0690 | |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
| NPI Number | 1275885766 |
| Organization Name | Coalinga Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 1147 Phelps Ave Coalinga, California, 93210 |
| Phone Number | (559) 934-0690 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 21 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 5 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 42 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 381 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Coalinga Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 42 |
| Hypercalcemia patient months | 391 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 42 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 19 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 24 |
| Patient months included in arterial venous fistula and catheter summaries | 248 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 83 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 5 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 26 |
| Hospitalization Rate in facility | 136.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 320.2 |
| Hospitalization Rate: Lower Confidence Limit | 62.3 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Coalinga Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 14.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35.1 |
| Readmission Rate: Lower Confidence Limit | 3.2 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Coalinga Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .44 (As Expected) |
| SIR: Upper Confidence Limit | 2.18 |
| SIR: Lower Confidence Limit | .02 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Coalinga Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 23 |
| Transfusion Rate in facility | 65.5 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 200.1 |
| Transfusion Rate: Lower Confidence Limit | 24.6 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at Coalinga Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 131 |
| Mortality Rate in facility | 12.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.1 |
| Mortality Rate: Lower Confidence Limit | 4.9 |
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago
News Archive
Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.
The project at the Centre for Performance Science, a cross-institutional partnership between the Royal College of Music and Imperial College London, will explore the impact of the arts and culture on health and wellbeing, from individual, social, and economic perspectives.
Avalon Healthcare, Florida's fast growing statewide individual and group health insurance plan, has signed a provider agreement with the Collier County based Physicians Regional Healthcare System, announced Charles T. O'Neill Avalon's Chief Executive Officer.
Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.
Serodus AS today announced that it has entered into a license agreement with Roche for a selective serotonin-4 (5-HT4) antagonist for the potential treatment of heart failure (RO1160367).
› Verified 7 days ago